Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Hanley

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The Journal of the Florida Medical Association|May 1, 1991
Bicycle safety. What's new in '92?J P Hanley
Journal of Clinical Pathology|October 29, 2004
Warfarin reversalJ P Hanley
Vox Sanguinis|December 20, 2005
Recombinant activated factor VII (rFVIIa/NovoSeven) in intractable haemorrhage: use of a clinical scoring system to predict outcomeT T Biss, J P Hanley
Leukemia & Lymphoma|July 31, 1998
The biology of interferon-alpha and the clinical significance of anti-interferon antibodiesJ P Hanley, G H Haydon
The Journal of the Florida Medical Association|May 1, 1979
TogethernessJ P Hanley, K K Hanley
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 29, 2006
Failure of rituximab to induce immune tolerance in a boy with severe haemophilia A and an alloimmune factor VIII antibody: a case report and review of the literatureT T Biss, M R Velangi, J P Hanley
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 18, 1998
Safety, efficacy and cost-effectiveness of home therapy with recombinant activated factor VII in a patient with severe haemophilia A and an anti-factor VIII inhibitorA J Stewart, J P Hanley, C A Ludlam
British Journal of Haematology|June 1, 1997
Liver biopsy in haemophiliaC A Ludlam, J P Hanley, P C Hayes
British Journal of Haematology|September 1, 1996
Development of anti-interferon antibodies and breakthrough hepatitis during treatment for HCV infection in haemophiliacsJ P Hanley, L M Jarvis, P Simmonds, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1991
Mechanism of promoter selection by RNA polymerase II: mammalian transcription factors alpha and beta gamma promote entry of polymerase into the preinitiation complexR C Conaway, K P Garrett, J P Hanley, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The Journal of the Florida Medical Association|May 1, 1991
Bicycle safety. What's new in '92?J P Hanley
Journal of Clinical Pathology|October 29, 2004
Warfarin reversalJ P Hanley
Vox Sanguinis|December 20, 2005
Recombinant activated factor VII (rFVIIa/NovoSeven) in intractable haemorrhage: use of a clinical scoring system to predict outcomeT T Biss, J P Hanley
Leukemia & Lymphoma|July 31, 1998
The biology of interferon-alpha and the clinical significance of anti-interferon antibodiesJ P Hanley, G H Haydon
The Journal of the Florida Medical Association|May 1, 1979
TogethernessJ P Hanley, K K Hanley
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 29, 2006
Failure of rituximab to induce immune tolerance in a boy with severe haemophilia A and an alloimmune factor VIII antibody: a case report and review of the literatureT T Biss, M R Velangi, J P Hanley
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 18, 1998
Safety, efficacy and cost-effectiveness of home therapy with recombinant activated factor VII in a patient with severe haemophilia A and an anti-factor VIII inhibitorA J Stewart, J P Hanley, C A Ludlam
British Journal of Haematology|June 1, 1997
Liver biopsy in haemophiliaC A Ludlam, J P Hanley, P C Hayes
British Journal of Haematology|September 1, 1996
Development of anti-interferon antibodies and breakthrough hepatitis during treatment for HCV infection in haemophiliacsJ P Hanley, L M Jarvis, P Simmonds, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1991
Mechanism of promoter selection by RNA polymerase II: mammalian transcription factors alpha and beta gamma promote entry of polymerase into the preinitiation complexR C Conaway, K P Garrett, J P Hanley, et al.
Pageof 3